Page 108 - 75_01

JOSÉ JAVIER LUCAS AN. R. ACAD. NAC. FARM.

15. Matz, M.V., Fradkov, A.F., Labas, Y.A., Savitsky, A.P., Zaraisky, A.G., Markelov,
M.L. & Lukyanov, S.A. (1999) Fluorescent proteins from nonbioluminescent
Anthozoa species. Nat. Biotechnol. 17: 969-973.

16. Heikal, A.A., Hess, S.T., Baird, G.S., Tsien, R.Y. & Webb, W.W. (2000) Molecular
spectroscopy and dynamics of intrinsically fluorescent proteins: coral red (dsRed)
and yellow (Citrine). Proc. Natl. Acad. Sci. U S A. 97: 11996-12001.

17. Campbell, R.E., Tour, O., Palmer, A.E., Steinbach, P.A., Baird, G.S., Zacharias,
D.A. & Tsien, R.Y. (2002) A monomeric red fluorescent protein. Proc. Natl. Acad.
Sci. U S A. 99: 7877-7882.

18. Roberto, F.F., Barnes, J.M. & Bruhn, D.F. (2002) Evaluation of a GFP reporter
gene construct for environmental arsenic detection. Talanta. 58: 181-188.

19. Gusella, J.F. & MacDonald, M.E. (1995) Huntington’s disease. Semin. Cell Bio.l
6: 21-28.

20. Martin Aparicio, E. & Lucas Lozano, J.J. (2002) Molecular basis of Huntington
s disease and possible pathogenic mechanisms. Rev. Neurol. 35: 212-220.

21. 2008. Transgenic primate models inch forward. Nat. Neurosci. 11: 729.
22. Yang, S.H., Cheng, P.H., Banta, H., Piotrowska-Nitsche, K., Yang, J.J., Cheng,

E.C., Snyder, B., Larkin, K., Liu, J., Orkin, J., et al. (2008) Towards a transgenic
model of Huntington’s disease in a non-human primate. Nature. 453: 921-924.
23. Glickman, M.H. & Ciechanover, A. (2002) The ubiquitin-proteasome proteolytic
pathway: destruction for the sake of construction. Physiol. Rev. 82: 373-428.
24. Dantuma, N.P., Lindsten, K., Glas, R., Jellne, M. & Masucci, M.G. (2000) Short-
lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent
proteolysis in living cells. Nat. Biotechnol. 18: 538-543.
25. Diaz-Hernandez, M., Torres-Peraza, J., Salvatori-Abarca, A., Moran, M.A.,
Gomez-Ramos, P., Alberch, J. & Lucas, J.J. (2005) Full motor recovery despite
striatal neuron loss and formation of irreversible amyloid-like inclusions in a con-
ditional mouse model of Huntington’s disease. J. Neurosci. 25: 9773-9781.
26. Yamamoto, A., Lucas, J.J. & Hen, R. (2000) Reversal of neuropathology and mo-
tor dysfunction in a conditional model of Huntington’s disease. Cell. 101: 57-66.
27. Lindsten, K., Menendez-Benito, V., Masucci, M.G. & Dantuma, N.P. (2003) A trans-
genic mouse model of the ubiquitin/proteasome system. Nat. Biotechnol. 21: 897-902.
28. Ortega, Z., Diaz-Hernandez, M. & Lucas, J.J. (2007) Is the ubiquitin-proteasome
system impaired in Huntington’s disease? Cell. Mol. Life Sci. 64: 2245-2257.
29. Livet, J., Weissman, T.A., Kang, H., Draft, R.W., Lu, J., Bennis, R.A., Sanes, J.R.
& Lichtman, J.W. (2007) Transgenic strategies for combinatorial expression of
fluorescent proteins in the nervous system. Nature. 450: 56-62.

* Información de contacto:
Dr. José J. Lucas.
Centro de Biología Molecular “Severo Ochoa”, CSIC/UAM.
C/ Nicolás Cabrera, 1. 28049 Madrid.
Tel 91 196 4552 / 91 196 4582. Fax 91 196 4420.
E-mail: jjlucas@cbm.uam.es
http://www.cbm.uam.es/lineas/joselucas.htm
http://www.ciberned.es/grupojoselucas.aspx

112